Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2608 | 2122 | 50.8 | 94% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2513 | 3376 | FOCAL ADHESION KINASE//INTEGRIN LINKED KINASE//FAK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FOCAL ADHESION KINASE | Author keyword | 181 | 40% | 17% | 352 |
2 | FAK | Author keyword | 132 | 37% | 13% | 282 |
3 | PYK2 | Author keyword | 63 | 52% | 4% | 86 |
4 | PAXILLIN | Author keyword | 43 | 30% | 6% | 122 |
5 | HIC 5 | Author keyword | 29 | 71% | 1% | 24 |
6 | FOCAL ADHESION KINASE FAK | Author keyword | 24 | 48% | 2% | 36 |
7 | FAK RELATED NON KINASE | Author keyword | 17 | 100% | 0% | 8 |
8 | FRNK | Author keyword | 15 | 77% | 0% | 10 |
9 | RAFTK | Author keyword | 9 | 83% | 0% | 5 |
10 | ANOIKIS | Author keyword | 7 | 12% | 3% | 55 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FOCAL ADHESION KINASE | 181 | 40% | 17% | 352 | Search FOCAL+ADHESION+KINASE | Search FOCAL+ADHESION+KINASE |
2 | FAK | 132 | 37% | 13% | 282 | Search FAK | Search FAK |
3 | PYK2 | 63 | 52% | 4% | 86 | Search PYK2 | Search PYK2 |
4 | PAXILLIN | 43 | 30% | 6% | 122 | Search PAXILLIN | Search PAXILLIN |
5 | HIC 5 | 29 | 71% | 1% | 24 | Search HIC+5 | Search HIC+5 |
6 | FOCAL ADHESION KINASE FAK | 24 | 48% | 2% | 36 | Search FOCAL+ADHESION+KINASE+FAK | Search FOCAL+ADHESION+KINASE+FAK |
7 | FAK RELATED NON KINASE | 17 | 100% | 0% | 8 | Search FAK+RELATED+NON+KINASE | Search FAK+RELATED+NON+KINASE |
8 | FRNK | 15 | 77% | 0% | 10 | Search FRNK | Search FRNK |
9 | RAFTK | 9 | 83% | 0% | 5 | Search RAFTK | Search RAFTK |
10 | ANOIKIS | 7 | 12% | 3% | 55 | Search ANOIKIS | Search ANOIKIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PP125FAK | 221 | 65% | 10% | 210 |
2 | FAK | 172 | 53% | 11% | 229 |
3 | FOCAL ADHESION KINASE | 104 | 13% | 35% | 741 |
4 | PAXILLIN | 65 | 31% | 8% | 179 |
5 | PYK2 | 42 | 46% | 3% | 69 |
6 | RAFTK | 27 | 92% | 1% | 11 |
7 | TIME PCR ANALYSES | 21 | 90% | 0% | 9 |
8 | EPITHELIAL SPECIFIC DISRUPTION | 18 | 55% | 1% | 23 |
9 | INTEGRIN DEPENDENT PHOSPHORYLATION | 17 | 100% | 0% | 8 |
10 | PROTEIN PAXILLIN | 16 | 58% | 1% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Focal adhesion kinase: In command and control of cell motility | 2005 | 1037 | 119 | 52% |
FAK in cancer: mechanistic findings and clinical applications | 2014 | 24 | 129 | 75% |
FAK signaling in human cancer as a target for therapeutics | 2015 | 2 | 265 | 73% |
Signal transduction by focal adhesion kinase in cancer | 2009 | 222 | 165 | 72% |
Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis | 2011 | 90 | 88 | 75% |
Transduction - Integrin signaling | 1999 | 2771 | 123 | 33% |
The role of focal-adhesion kinase in cancer. A ew therapeutic opportunity | 2005 | 489 | 117 | 68% |
Understanding the Roles of FAK in Cancer: Inhibitors, Genetic Models, and New Insights | 2015 | 1 | 113 | 81% |
Focal adhesion kinase and tumour angiogenesis | 2012 | 38 | 76 | 80% |
Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasis | 2010 | 76 | 169 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VASC ADHES | 4 | 67% | 0.2% | 4 |
2 | HARVARD MED EXPT MED | 4 | 75% | 0.1% | 3 |
3 | STOMATOL ANAT | 3 | 60% | 0.1% | 3 |
4 | CANC BIOL S | 3 | 26% | 0.4% | 9 |
5 | COMPREHENS INFLAMMATORY DISORDERS | 3 | 20% | 0.5% | 11 |
6 | ADHES ANGIOGENESIS TUMOUR BIOL | 2 | 67% | 0.1% | 2 |
7 | FEDERAT RECH CLAUDE DE PREVAL | 2 | 67% | 0.1% | 2 |
8 | UNITA ONCOL MOL | 2 | 67% | 0.1% | 2 |
9 | INTERNAL MED MMG | 2 | 43% | 0.1% | 3 |
10 | HERITAGE MED 670 | 1 | 38% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000160313 | NEDD9//HEF1//CRK |
2 | 0.0000123601 | SCHLAFEN//SURG SERV 11S//SCHLAFEN 3 |
3 | 0.0000100774 | INTEGRIN LINKED KINASE//ILK//INTEGRIN LINKED KINASE ILK |
4 | 0.0000094888 | LCK INHIBITOR//SRC INHIBITORS//SRC |
5 | 0.0000091182 | VINCULIN//TALIN//VINEXIN |
6 | 0.0000085254 | ALPHA 6 BETA 4 INTEGRIN//INTEGRIN ALPHA 6 BETA 4//CANC BIOL ANGIOGENESIS |
7 | 0.0000083889 | SERV 151Z2//PP 2A//STRITCH MED OTOLARYNGOL |
8 | 0.0000073592 | CDCP1//TRASK//SUBTRACTIVE IMMUNIZATION |
9 | 0.0000072316 | CDKN3//CYCLIN DEPENDENT KINASE ASSOCIATED PROTEIN PHOSPHATASE//CYTOKINE EXPRESSION PATTERN |
10 | 0.0000069039 | TELENCEPHALIN//ICAM 5//NEURONAL RECOGNIT MOL |